Avastin effective at delaying brain tumour progression in recurrent disease

The use of Avastin alone to treat a subgroup of recurrent Grade 3 brain tumours showed it was safe and effective at delaying tumour progression, according to a retrospective study of 22 patients conducted by a researcher at the Seattle Cancer Care Alliance...

Read the whole article on

More from